Women's Health

>

Latest News

 ©arturfoto stock.adobe.com
Maternal Time Above Target Glucose Range as Measured by CGM Linked to Adverse Neonatal Outcomes

November 15th 2023

Individuals assessed for GDM whose time above target level was greater than 10% by CGM measure had a 63% increased risk of poor newborn outcomes.

Common Menstrual Disorders Increase Risk for Future CVD in Young Women image credit women heart disease: ©Rysis/stock.adobe.com
Common Menstrual Disorders Increase Risk for Future CVD in Young Women

November 15th 2023

Migraine in Pregnancy: Considerations for Treatment / Image credit: ©Prostock-studio/AdobeStock
Migraine in Pregnancy: Considerations for Treatment

October 27th 2023

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Obesity Linked to Higher Risk for Breast Cancer Recurrence

October 26th 2023

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Obesity Before and During Pregnancy Predicts Future CV Health

October 24th 2023

Latest CME Events & Activities

Tumor Agnostic Trials and the Reshaping of Precision Medicine in Oncology: A Focus on TSC1/2 Mutations

View More

Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Reflective Case-Based Oncology Collective: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer

View More

Advances In™: Meeting Unmet Clinical Needs in TNBC and HR+ Breast Cancer with TROP2-Targeted Regimens

View More

Oncology Consultations®: Clinical Impact of HER2-Low Expressing Breast Cancer and Novel Targeted Therapies to Address Unmet Needs in Care

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

View More

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Community Practice Connections™: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer

View More

School of Breast Oncology

View More

41st Annual Miami Breast Cancer Conference®

Register Now!

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the Opioid Epidemic

View More

Identifying and Mitigating Disparities in Breast Cancer Care: Improving Diagnostics, Trial Access and Care for All Patients

View More

Medical Crossfire®: Optimizing Treatment Sequencing for HR+/HER2- Metastatic Breast Cancer Based on Emerging Evidence and Evolving Algorithms

View More

Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis

View More

Medical Crossfire®: How Have HER2-Low Expressing Breast Cancers and Novel Advances in the Field Redefined Care As We Knew It?

View More

Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?

View More

Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer

View More

Show Me Your Care Plan: Nursing Considerations for Managing Breast Cancer Patients

View More

15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

View More

Community Practice Connections™: The Newest Frontier in HR+ Breast Cancer—Targeting ESR1 Mutations with Next-Generation Endocrine Therapy

View More

Clinical Case Vignette Series™: 40th Annual Miami Breast Cancer Conference®

View More

More News

© 2023 MJH Life Sciences

All rights reserved.